Agios Pharmaceuticals, Inc. - AGIO

About Gravity Analytica
Recent News
- 02.12.2026 - Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- 01.26.2026 - Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET
- 01.12.2026 - Agios Outlines 2026 Strategic Priorities and Key Milestones to Accelerate Rare Disease Portfolio Growth
- 01.05.2026 - Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Recent Filings
- 02.12.2026 - 8-K Current report
- 02.12.2026 - EX-99.1 EX-99.1
- 02.09.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.09.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
- 01.12.2026 - EX-99.1 EX-99.1
- 01.12.2026 - 8-K Current report
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.05.2026 - 144 Report of proposed sale of securities
- 01.02.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.02.2026 - 4 Statement of changes in beneficial ownership of securities